company background image
2161 logo

JBM (Healthcare) SEHK:2161 Stock Report

Last Price

HK$0.94

Market Cap

HK$778.3m

7D

-1.1%

1Y

-8.7%

Updated

14 Jun, 2024

Data

Company Financials

JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$778.3m

2161 Stock Overview

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded, healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

JBM (Healthcare) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for JBM (Healthcare)
Historical stock prices
Current Share PriceHK$0.94
52 Week HighHK$1.30
52 Week LowHK$0.77
Beta0.35
1 Month Change-7.84%
3 Month Change-1.05%
1 Year Change-8.74%
3 Year Change-37.33%
5 Year Changen/a
Change since IPO-56.48%

Recent News & Updates

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Recent updates

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Shareholder Returns

2161HK PharmaceuticalsHK Market
7D-1.1%-1.4%-1.5%
1Y-8.7%-4.9%-2.6%

Return vs Industry: 2161 underperformed the Hong Kong Pharmaceuticals industry which returned -4.9% over the past year.

Return vs Market: 2161 underperformed the Hong Kong Market which returned -2.6% over the past year.

Price Volatility

Is 2161's price volatile compared to industry and market?
2161 volatility
2161 Average Weekly Movement5.9%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 2161 has not had significant price volatility in the past 3 months.

Volatility Over Time: 2161's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2020258Patrick Wongwww.jbmhealthcare.com.hk

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded, healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients.

JBM (Healthcare) Limited Fundamentals Summary

How do JBM (Healthcare)'s earnings and revenue compare to its market cap?
2161 fundamental statistics
Market capHK$778.33m
Earnings (TTM)HK$97.99m
Revenue (TTM)HK$610.30m

7.9x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2161 income statement (TTM)
RevenueHK$610.30m
Cost of RevenueHK$319.22m
Gross ProfitHK$291.09m
Other ExpensesHK$193.10m
EarningsHK$97.99m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Jun 18, 2024

Earnings per share (EPS)0.12
Gross Margin47.70%
Net Profit Margin16.06%
Debt/Equity Ratio11.9%

How did 2161 perform over the long term?

See historical performance and comparison

Dividends

7.3%

Current Dividend Yield

55%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.